The administrative core will be ensuring the integrity and the integrafion of the program projects. The directors and staff members will be overseeing the following special tasks: 1. Program Management - The core director will set specific program aims in a timely manner to maintain program goals. He will propose strategies to overcome any shortcomings and consult with external/internal board members to resolve them to achieve integration of program goals. To ascertain the integrity of the program projects, the director will implement collaborafive research agreements among institutions involved in the program projects, and employ consultancy agreements with the external/internal advisory members. 2. Program Coordination and Communication - The administrafive core will establish effecfive communication with program members to communicate on a daily basis and access information and announcements. The core staff will coordinate meefings. Additionally, to conduct ongoing research more effecfively, the core director and program members will share scientific literature and attend national and international conferences related to their projects. A steering committee composed of the four project leaders and the primary statistician will meet quartely or whenever necessary through teleconferences to update program progress. The director and staff will distribute data, announce any significant discoveries, edit manuscripts and prepare meeting abstracts. The staff members will collect experimental data and publication lists for annual progress reports for the external/internal advisory board members and for program continuation applicafion. 3. Program Evaluation - To enhance interacfions and integration among projects, Dr. Muller will continue to join monthly workshops through teleconference, and the annual external/internal advisory review meefing will be held separately during Dr. Muller's visit. The four project leaders will submit written reports before meefings and the orally present project progress and propose future strategies during the meefings. The external/internal advisory board will summarize critiques to improve the program projects.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA099031-07
Application #
8328565
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2011-09-01
Budget End
2012-08-31
Support Year
7
Fiscal Year
2011
Total Cost
$90,572
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Yamaguchi, H; Du, Y; Nakai, K et al. (2018) EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer. Oncogene 37:208-217
Joshi, Sonali; Yang, Jun; Wang, Qingfei et al. (2017) 14-3-3? loss impedes oncogene-induced mammary tumorigenesis and metastasis by attenuating oncogenic signaling. Am J Cancer Res 7:1654-1664
Jones, Laura M; Broz, Miranda L; Ranger, Jill J et al. (2016) STAT3 Establishes an Immunosuppressive Microenvironment during the Early Stages of Breast Carcinogenesis to Promote Tumor Growth and Metastasis. Cancer Res 76:1416-28
Park, Yun-Yong; Sohn, Bo Hwa; Johnson, Randy L et al. (2016) Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma. Hepatology 63:159-72
Lim, Seung-Oe; Li, Chia-Wei; Xia, Weiya et al. (2016) Deubiquitination and Stabilization of PD-L1 by CSN5. Cancer Cell 30:925-939
Lucenay, Kimberly S; Doostan, Iman; Karakas, Cansu et al. (2016) Cyclin E Associates with the Lipogenic Enzyme ATP-Citrate Lyase to Enable Malignant Growth of Breast Cancer Cells. Cancer Res 76:2406-18
Hsu, Ming-Chuan; Hung, Wen-Chun; Yamaguchi, Hirohito et al. (2016) Extracellular PKM2 induces cancer proliferation by activating the EGFR signaling pathway. Am J Cancer Res 6:628-38
Acharya, Sunil; Xu, Jia; Wang, Xiao et al. (2016) Downregulation of GLUT4 contributes to effective intervention of estrogen receptor-negative/HER2-overexpressing early stage breast disease progression by lapatinib. Am J Cancer Res 6:981-95
Chen, Mei-Kuang; Hung, Mien-Chie (2016) Regulation of therapeutic resistance in cancers by receptor tyrosine kinases. Am J Cancer Res 6:827-42
Boulay, Pierre-Luc; Mitchell, Louise; Turpin, Jason et al. (2016) Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression. Cancer Res 76:2662-74

Showing the most recent 10 out of 204 publications